8-K

                                 UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549

                                    FORM 8-K

                       Pursuant to Section 13 or 15(d) of
                       The Securities Exchange Act of 1934



        Date of Report (date of earliest event reported): April 19, 2005


                           Commission File No. 0-11178
                                               -------


                           UTAH MEDICAL PRODUCTS, INC.
                           ---------------------------
             (Exact name of Registrant as specified in its charter)


                UTAH                                       87-0342734
   -------------------------------                    ------------------
   (State or other jurisdiction of                     (I.R.S. Employer
   incorporation or organization)                     Identification No.)


                               7043 South 300 West
                               Midvale, Utah 84047
                               -------------------
                     Address of principal executive offices


Registrant's telephone number:      (801) 566-1200
                                    --------------











- --------------------------------------------------------------------------------

             ITEM 2.02 RESULTS OF OPERATIONS AND FINANCIAL CONDITION

- --------------------------------------------------------------------------------


On April 19, 2005, Utah Medical Products, Inc. issued a press release, a copy of
which is attached hereto as Exhibit 99.1


- --------------------------------------------------------------------------------

                       ITEM 7.01 REGULATION FD DISCLOSURE

- --------------------------------------------------------------------------------


On April 19, 2005, Utah Medical Products, Inc. issued a press release, a copy of
which is attached hereto as Exhibit 99.1


- --------------------------------------------------------------------------------

                                   SIGNATURES

- --------------------------------------------------------------------------------


Pursuant to the requirements of the Securities Exchanges Act of 1934, the
Registrant has duly caused this report to be signed on its behalf by the
undersigned thereunto duly authorized.


                                           UTAH MEDICAL PRODUCTS, INC.
                                           ---------------------------
                                           REGISTRANT


Date:     4/19/05                          By:  /s/ Kevin L. Cornwell
      ---------------                         -----------------------
                                              Kevin L. Cornwell
                                              CEO



- --------------------------------------------------------------------------------

                                  EXHIBIT INDEX


Index
Number         Description
- ------         -----------
99.1           Press release issued April 19, 2005: Utah Medical Products
               Announces Earnings Release Date/Time for First Quarter 2005, and
               Conference Call Information

EX-99.1

                                  EXHIBIT 99.1

Salt Lake City, Utah - Utah Medical Products, Inc. (NASDAQ: UTMD) will release
its financial results for the first quarter ending March 31, 2005 (1Q 2005) near
the stock market opening on Thursday, April 21, 2005, the 27th birthday of the
Company.


According to CEO Kevin Cornwell, "UTMD's steady performance in 1Q 2005 supports
achieving management's goal of $1.80 in earnings per share for the year of 2005.
This projection includes a lower income tax provision as a result of The
American Jobs Creation Act of 2004 (the Act) enacted in October 2004 which
allows a temporary tax deduction on repatriated foreign earnings, which must be
accomplished in 2005."

Because of the unusual tax consequences of repatriating foreign earnings in
2005, and the extraordinary events in prior periods of 2004, to which 2005
performance from continuing operations will be compared, UTMD will hold an
investor conference call on the same day (Thursday, April 21, 2005) to answer
investor questions and explain the differences between Generally Accepted
Accounting Principles (GAAP) and the non-GAAP measures of performance which UTMD
also provides, and why the Company believes the non-GAAP measures are important
to investors' "apples to apples" comparisons of UTMD's performance with prior
periods.

The conference call is scheduled for 4:15 p.m. Eastern (2:15 p.m. Mountain) time
on Thursday, April 21. The telephone number to call is 1-800-579-2557. Please
call in a few minutes prior to the scheduled start of the call, using passcode
7039844.

Investors are cautioned that this press release contains forward looking
statements and that actual events may differ from those projected. Risk factors
that could cause results to differ materially from those projected include a
delay in adjudication of UTMD's current lawsuit with the Food & Drug
Administration (FDA) beyond the middle of 2005, an unfavorable outcome of the
lawsuit with the FDA, and a change in the guidance provided by FASB Staff
Position No. FAS 109-2 regarding accounting for the tax consequences of
repatriating foreign earnings in 2005, among other factors that have been
outlined in UTMD's public disclosure filings with the SEC.

Utah Medical Products, Inc., with particular interest in health care for women
and their babies, develops, manufactures, assembles and markets a broad range of
high quality disposable and reusable specialty medical devices designed for
better health outcomes for patients and their care-providers. For more
information about Utah Medical Products, Inc., visit UTMD's website at
www.utahmed.com.